title: Prevention of diabetic nephropathy.
abstract: Normalization of blood pressure--and use of an ACE inhibitor or AT1-receptor blocker for patients with abnormal albumin or creatinine levels--can prevent or significantly slow the rate of progression toward end-stage renal disease.
authors.affiliation: University of Miami, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Materson
authors.forename: R A
authors.initials: RA
authors.lastname: Preston
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D003928:Diabetic Nephropathies / Q000503:physiopathology* / Q000517:prevention & control*; D004656:Enalapril / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril